PE - 医索

找到约 1072 条结果

Lorlatinib in TKl naive, advanced RoS1-positivenon-small cell lung cancer a multicenter, open-label, single-arm, phase 2 trial

医客学院 - 会议报告集

Health-Related Quality of Life Outcomes From the Randomized, Double-Blind Phase 3 KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC

医客学院 - 会议报告集

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas (DPM) Results of a prospective pilot study

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

Clinical outcomes with perioperative nivolumab bynodal status among patients with stage lll resectableNSCLCresults from the phase 3 CheckMate 77T study

医客学院 - 会议报告集

Total neoadjuvant treatment with long-course radiotherapyversus concurrent chemoradiotherapy in local advanced rectalcancer with high risk factors (TNTCRT)A multicenter,randomized, open-label, phase

医客学院 - 会议报告集

Time dependency for HPV ctDNAdetection as a prognostic biomarkerfor anal cancer

医客学院 - 会议报告集

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Neoadiuvant Pembrolizumab stratified to tumourmutation burden for High-Risk Stage 2 or Stage 3deficient-MMRMSl-High Colorectal CancerThe multicentre Phase 2 NEOPRISM-CRC trial

医客学院 - 会议报告集

今日实时热搜